These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 30351503)

  • 1. Insights into the genetic epidemiology of spinal and bulbar muscular atrophy: prevalence estimation and multiple founder haplotypes in the Veneto Italian region.
    Bertolin C; Querin G; Martinelli I; Pennuto M; Pegoraro E; Sorarù G
    Eur J Neurol; 2019 Mar; 26(3):519-524. PubMed ID: 30351503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple founder effects in spinal and bulbar muscular atrophy (SBMA, Kennedy disease) around the world.
    Lund A; Udd B; Juvonen V; Andersen PM; Cederquist K; Davis M; Gellera C; Kölmel C; Ronnevi LO; Sperfeld AD; Sörensen SA; Tranebjaerg L; Van Maldergem L; Watanabe M; Weber M; Yeung L; Savontaus ML
    Eur J Hum Genet; 2001 Jun; 9(6):431-6. PubMed ID: 11436124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Founder effect in spinal and bulbar muscular atrophy (SBMA) in Scandinavia.
    Lund A; Udd B; Juvonen V; Andersen PM; Cederquist K; Ronnevi LO; Sistonen P; Sörensen SA; Tranebjaerg L; Wallgren-Pettersson C; Savontaus ML
    Eur J Hum Genet; 2000 Aug; 8(8):631-6. PubMed ID: 10951525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wide range of reduced penetrance alleles in spinal and bulbar muscular atrophy: a model-based approach.
    Laskaratos A; Breza M; Karadima G; Koutsis G
    J Med Genet; 2021 Jun; 58(6):385-391. PubMed ID: 32571900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Two brothers with very late onset of muscle weakness in X-linked recessive spinal and bulbar muscular atrophy].
    Hemmi S; Inoue K; Kutoku Y; Rikimaru M; Murakami T; Sunada Y
    Rinsho Shinkeigaku; 2009 Jan; 49(1):22-6. PubMed ID: 19227892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Vitro and In Vivo Modeling of Spinal and Bulbar Muscular Atrophy.
    Pennuto M; Basso M
    J Mol Neurosci; 2016 Mar; 58(3):365-73. PubMed ID: 26614347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Onset Manifestations of Spinal and Bulbar Muscular Atrophy (Kennedy's Disease).
    Finsterer J; Soraru G
    J Mol Neurosci; 2016 Mar; 58(3):321-9. PubMed ID: 26482145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and prevalence of Spinal and bulbar muscular atrophy in South Korea: a nationwide population-based study.
    Park JM; Kang M; Park JS
    J Neurol; 2023 Oct; 270(10):5017-5022. PubMed ID: 37389590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis and molecular targeted therapy of spinal and bulbar muscular atrophy (SBMA).
    Banno H; Katsuno M; Suzuki K; Tanaka F; Sobue G
    Cell Tissue Res; 2012 Jul; 349(1):313-20. PubMed ID: 22476656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between the CAG repeat size and electrophysiological findings in patients with spinal and bulbar muscular atrophy.
    Kim H; Lim YM; Lee EJ; Oh YJ; Kim KK
    Muscle Nerve; 2018 Apr; 57(4):683-686. PubMed ID: 28972672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypospadias as a novel feature in spinal bulbar muscle atrophy.
    Nordenvall AS; Paucar M; Almqvist C; Nordenström A; Frisén L; Nordenskjöld A
    J Neurol; 2016 Apr; 263(4):703-6. PubMed ID: 26872663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Founder effect in spinal and bulbar muscular atrophy (SBMA).
    Tanaka F; Doyu M; Ito Y; Matsumoto M; Mitsuma T; Abe K; Aoki M; Itoyama Y; Fischbeck KH; Sobue G
    Hum Mol Genet; 1996 Sep; 5(9):1253-7. PubMed ID: 8872464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical features of a genetically identified spinal and 
bulbar muscular atrophy pedigree].
    Wang Z; Chen Q; Li Q; Bi F
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Oct; 41(10):1101-1105. PubMed ID: 27807335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the androgen receptor CAG repeat polymorphism in prostate cancer, and spinal and bulbar muscular atrophy.
    Kumar R; Atamna H; Zakharov MN; Bhasin S; Khan SH; Jasuja R
    Life Sci; 2011 Mar; 88(13-14):565-71. PubMed ID: 21284948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial DNA damage in spinal and bulbar muscular atrophy patients and carriers.
    Su S; Jou S; Cheng W; Lin T; Li J; Huang C; Lee Y; Soong B; Liu C
    Clin Chim Acta; 2010 May; 411(9-10):626-30. PubMed ID: 20035733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Disease-modifying therapy for spinal and bulbar muscular atrophy (SBMA)].
    Suzuki K; Banno H; Katsuno M; Adachi H; Tanaka F; Sobue G
    Brain Nerve; 2012 Mar; 64(3):237-44. PubMed ID: 22402717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular pathophysiology and disease-modifying therapies for spinal and bulbar muscular atrophy.
    Katsuno M; Banno H; Suzuki K; Adachi H; Tanaka F; Sobue G
    Arch Neurol; 2012 Apr; 69(4):436-40. PubMed ID: 22158719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Introduction to the Special Issue on Spinal and Bulbar Muscular Atrophy.
    Pennuto M; Gozes I
    J Mol Neurosci; 2016 Mar; 58(3):313-6. PubMed ID: 26875173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of the Androgen Receptor by Antiandrogens in Spinobulbar Muscle Atrophy.
    Baniahmad A
    J Mol Neurosci; 2016 Mar; 58(3):343-7. PubMed ID: 26563449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebral involvement in spinal and bulbar muscular atrophy (Kennedy's disease): a pilot study of PET.
    Lai TH; Liu RS; Yang BH; Wang PS; Lin KP; Lee YC; Soong BW
    J Neurol Sci; 2013 Dec; 335(1-2):139-44. PubMed ID: 24120273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.